Autonomous Therapy System Market Size (2024 – 2030):

According to recent research, the global Autonomous Therapy System Market attained a value of USD 1.8 billion in 2023 and is projected to reach USD 3.41 billion by 2030, with a compound annual growth rate (CAGR) of 9.6%. The market expansion is attributed to various factors including the escalating demand for precise laparoscopic surgeries, the increasing necessity for surgical interventions among the elderly population, and the surge in trauma injury cases. Furthermore, the substantial rise in per capita healthcare expenditure and the advancements in surgical medical equipment technology are significantly propelling the growth trajectory of this industry.

Autonomous Therapy Industry Overview:

The landscape of medical robot systems is witnessing a transformative shift due to technological advancements across multiple domains such as high-definition surgical microscope cameras, 3D imaging, motion sensors, data loggers, motion analyzers, and robotic catheter control systems (CCS) along with remote navigation capabilities. Notably, the da Vinci surgical system, prominently utilized by Intuitive Surgery Inc., exemplifies the integration of computer systems capable of performing laparoscopic surgery.

The progressive evolution of medical technologies underscores the rapid progress in medical robotic systems. Initiatives like ProvenCare, spearheaded by Geisinger Health System, ensure patients' coverage with guaranteed insurance post 90 days of follow-up admission, aimed at mitigating surgical errors, complications, and associated costs.

The future trajectory of robotics technology is poised to explore novel functionalities for existing processes, thereby augmenting the demand for medical robots. The market is witnessing a steady rise in technology transfer partnerships with third-party vendors to foster the development of innovative applications for robotic systems.

According to FDA data, the utilization of robots in the United States surged from 25,000 to 450,000 annually between 2005 and 2012. Additionally, statistics from the National Cancer Institute (NCI) suggest that around 80% of prostate removal surgeries in 2014 were conducted using medical robots, compared to merely 1% of all surgeries in 2001. The escalating penetration of technologically advanced robotic systems is anticipated to sustain the demand dynamics over the forthcoming years.

COVID-19 Impact on Autonomous Therapy System Market:

The global outbreak of COVID-19 has emerged as a pivotal stress test, amplifying concerns regarding global economic growth amidst escalating infection rates worldwide. Notably, the pandemic has fueled the prominence of robots, drones, and artificial intelligence technologies. The robotics industry is witnessing a surge in demand for professional service robots, instrumental in bolstering essential infrastructure operations and alleviating strains in the supply chain. Moreover, these technologies have played a pivotal role in mitigating significant workforce shortages across healthcare, industrial, and supply chain sectors, while facilitating adherence to social distancing norms and enhancing pandemic detection and response capabilities.

Market Drivers:

The burgeoning prevalence of medication errors is serving as a key driver for market growth.

Medication errors entail unintended failures in the drug treatment process, posing substantial risks to patients' health. Errors spanning prescription, preparation, storage, dispensation, and administration of medications represent prevalent preventable causes of adverse events, exerting a considerable burden on public health. The adoption of comprehensive and accurate Electronic Health Records (EHRs), facilitating access to patients' complete medical histories, is instrumental in ensuring optimal care delivery. Effective implementation and utilization of Clinical Decision Support Systems (CDSS) and allied systems are imperative for hospitals and healthcare practitioners worldwide to enhance diagnostic accuracy, prevent errors, streamline processes, and mitigate patient waiting times, thereby driving their global adoption.

Market Restraints:

Concerns pertaining to data security associated with cloud-based CDSS pose a significant restraint to market growth.

Notably, a major apprehension surrounding cloud-based CDSS lies in the perceived vulnerability of data stored by providers compared to its on-premise counterparts. Given the sensitive nature of patient information, stringent confidentiality measures must be upheld, ensuring access solely to authorized users. Regulatory frameworks, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the European Data Protection Regulation in the European Union, mandate stringent data privacy requirements, particularly concerning the protection of sensitive health data. The transfer of patients' Protected Health Information (PHI) across borders is subject to stringent regulations in numerous jurisdictions. While private clouds offer enhanced access protocols and systems, concerns persist within the healthcare industry regarding their efficacy, mirroring the broader security issues associated with public clouds and traditional IT systems.

Autonomous Therapy System Market – By Product

• Surgical Robots
• Rehabilitation Robots
• Non-Invasive Radiosurgery Robots
• Hospital and Pharmacy Robots
• Emergency Response Robotic Systems

Categorized by product, medical robot systems comprise Surgical Robots, Non-Invasive Surgical Robotic Systems, Robotic Emergency Response Systems, Prosthetics, Support and Rehabilitation Systems, and Non-medical Hospital Robotics systems. Surgical robots held the majority market share in 2014, accounting for 65% of the market, driven by heightened adoption rates in hospitals and escalating demand for minimally invasive surgeries.

Furthermore, technological advancements addressing limitations in laparoscopic surgery, such as the Da Vinci surgery offering enhanced precision and consistent outcomes, are poised to fuel market growth during the forecast period. The upsurge in surgical procedures is anticipated to propel the demand for medical robots from 2014 to 2022.

The burgeoning acceptance of assistive and rehabilitation systems for physical therapy in managing stroke and motor disability-associated neurological disorders is expected to underpin growth. Concurrently, with the increasing significance of disease treatment methodologies, the count of patients treated using medical robots is on the rise. The non-medical hospital products segment is forecasted to emerge as the fastest-growing segment, with a projected CAGR of 16.8%. Factors such as institutional centralization and the expanding healthcare IT market are anticipated to bolster the demand for medical robotic systems.

Autonomous Therapy System Market - By Application

• Neurology
• Orthopedics Robotic Systems
• Laparoscopy
• Special Education
• Others

Segmented by application, robotic systems encompass neurology, orthopedics, laparoscopy, and other applications. Neurology is anticipated to witness the swiftest growth with a projected CAGR of 16.7% during this period, attributed to the global surge in neurological disorders like Alzheimer's disease and depression. Technological advancements in NeuroMate system hardware and software, along with progress in robotic neurotechnology, are expected to drive widespread adoption. Additionally, innovations such as the development of RoboDoc by ULCA Neurosurgery, a mobile robot facilitating surgeon-led patient monitoring without physical relocation, are poised to spur further advancements.

Laparoscopy dominated the application segment in 2014 with a CAGR of 12.3%. Advancements in new systems offering enhanced maneuverability, magnification, and device manipulation, coupled with improved micro-motions within the patient's body, are anticipated to enhance surgical procedure accuracy. Moreover, these robotic systems, tailored to surgeons' requirements, are deemed technically feasible. Market growth is further fueled by factors like the burgeoning geriatric populace, escalating demand for endoscopic diagnostic and therapeutic procedures, and the rising prevalence of unhealthy lifestyle habits.

Orthopedic robotic systems are projected as the second-fastest-growing application segment, with a forecasted CAGR of 14.2% from 2015 to 2022. Substantial growth in software utilized for procedures like total hip arthroplasty (THA), total knee arthroplasty (TKA), and anterior cruciate ligament (ACL) knee reconstruction is anticipated to spur demand for minimally invasive robotic surgeries. The uptick in musculoskeletal conditions like rheumatoid arthritis, low back pain, osteoarthritis, and osteoporosis is expected to drive the need for robot-assisted surgeries.

Autonomous Therapy System Market - By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East
• Africa

Geographically, North America spearheaded the medical robotics systems domain with a 49.7% market share in 2014, while Asia-Pacific is anticipated to register the fastest growth with a projected CAGR of 15.6%. The burgeoning geriatric populace, coupled with incidents of low bone density and accidental injuries, is slated to positively influence market expansion in the forthcoming years.

Asia-Pacific is poised for rapid growth during this period, buoyed by emerging opportunities, enhanced healthcare infrastructure, and heightened disease awareness. The growing penetration of minimally invasive surgeries serves as a key growth catalyst. Innovations such as capsule robotic systems, engineered software, and imaging systems aimed at mitigating surgical procedure complications are anticipated to bolster market growth. Key product segments contributing to Asia Pacific's growth include surgical robots and non-invasive radiosurgery systems.

The European medical robotic systems market is expected to trail Asia-Pacific, exhibiting a CAGR of 11.7% from 2015 to 2022. Surgical practices are rapidly evolving, with technology increasingly replacing conventional surgeries, offering efficient procedures with reduced health risks, accelerated patient recovery, and minimized scarring. These factors are poised to propel market growth in the region.

Autonomous Therapy System Market Share by Company

1. MAKO Surgical Corp
2. Renishaw Plc.
3. Varian
4. Accuray
5. Intuitive Surgical Inc
6. Health robotics S.R.L.

Market players are strategically enhancing their market share by tapping into untapped economies and expanding their product portfolios. Additionally, major companies are introducing new products to maintain their competitive edge, thereby bolstering market growth.

Developed economies like North America and Europe exhibit higher entry barriers compared to developing economies such as Asia-Pacific. Owing to lower entry barriers and lucrative market prospects, Asia-Pacific is expected to witness swifter growth from 2022 to 2030.

Suppliers are heavily investing in research and development to introduce technologically advanced systems, gaining a competitive advantage and contributing to industry growth. The industry is poised for several mergers and acquisitions in the coming years, as companies strive to augment their market share and diversify their product offerings.

NOTABLE EVENTS IN THE AUTONOMOUS THERAPY SYSTEM MARKET IN RECENT TIMES:

• Product Launch - In April 2021, Epic and OCHIN unveiled the COVID-19 Preparedness Screening app, enhancing interoperability, care coordination, and overall clinical readiness in Washington, US.

Collaboration - In April 2020, Cerner extended its collaboration with Tenet Healthcare Corporation to leverage Cerner’s IT solutions across Tenet’s hospitals, fostering patient and provider engagement.